Chemotherapy and radiotherapy are essential in the treatment of certain childhood CNS tumours. Unfortunately, their well-known neurotoxic potential may cause CNS injury, especially in childhood. This study describes literature reports on the possible neurotoxic damage caused by chemotherapy and radiotherapy and our own experience in the MR follow-up of 58 patients.
DropchoEJ: Central nervous system injury by therapeutic irradiation. Neurol Clin9 (4): 969–988, 1991.
2.
HopewellJW: Late radiation damage to the central nervous system: A radio-biological interpretation. Neuropathol Appl Neurobiol5 (5): 329–343, 1979.
3.
HonkaniemiJKaharaV: Reversible posterior leukoecephalopathy after combination chemotherapy. Neuroradiology42: 895–899, 2000.
4.
van der KnaapMSValkJ: Leukoencephalopathy after Chemotherapy and/or Radiotherapy. Magnetic Resonance of Myelin, Myelination, and Myelin Disorders. 2nd edition, Springer-Verlag.
5.
ValkPDillonWP: Radiation Injury of the Brain. Am J Neuroradiol12: 45–62, 1991.
6.
StemmerSMStearsJC: White Matter Changes in Patients with Breast Cancer Treated with High-Dose Chemotherapy and Autologous Bone Marrow Support. Am J Neuroradiol15: 1267–1273, 1994.
7.
Hecht-LeavittCGrossmanRI: MR of Brain Radiation Injury: Experimental Studies in Cats. Am J Neuroradiol8, 1987.
8.
TsurudaJSKortmanKE: Radiation Effects on Cerebral white Matter: MR evaluation. Am J Neuroradiol8, 1987.
9.
StoneJACastilloM: Leukoencephalopathy complicating an Ommaya reservoir and chemotherapy. Neuroradiology41: 134–136, 1999.
10.
ReddickaijWERussellJM: Subtle white matter volume differences in children treated for medulloblastoma with conventional or reduced dose craniospinal irradiation. Magn Reson Imaging18 (7): 787–793, 2000.
11.
HecklSAschoffA: Radiation-induced cavernous haemangiomas of the brain: A late effect predominantly in children. Cancer94 (12): 3285–3291, 2002.
12.
TashimaTMoriokaT: Delayed cerebral radionecrosis with a high uptake of 11C-methionine on positron emission tomography and 201Tl-chloride on single-photon emission computed tomography. Neuroradiology40: 435–438, 1998.
13.
SchlemmerHPBachertP: Differentiation of radiation necrosis from tumor progression using proton magnetic resonance spectroscopy. Neuroradiology44: 216–222, 2002.
14.
BallWSPrengerEC: Neurotoxicity of Radio/Chemotherapy in Children: Pathologic and MR correlation. Am J Neuroradiol13, 1992.
15.
KocsisBSzekelyG: Postoperative radiotherapy of childhood medulloblastomas. Neoplasma48 (4): 320–323, 2001.
16.
SugaharaTKorogiY: Post therapeutic Intraaxial Brain Tumor: The Value of Perfusion-sensitive Contrastenhanced MR Imaging for Differentiatig Tumor Recurrence from Nonneoplastic Contrast-enhancing Tissue. Am J Neuroradiol21: 901–909, 2000.
17.
SchlemmerH-PBachertP: Proton MR Spectroscopic Evaluation of Suspicious Brain Lesions After Stereotactic Radiotherapy. Am J Neuroradiol22: 1316–1324, 2001.
18.
SawataishyJMineuraK: Effects of radiotherapy determined by 11C-methyl-L-methionine positron emission tomography in patients with primary cerebral malignant lymphoma. Neuroradiology34: 517–519, 1992.
